Point72 Asset Management »

Aptevo Therapeutics shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Aptevo Therapeutics (APVO) shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Aptevo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aptevo Therapeutics held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aptevo Therapeutics by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $435k 300k 1.45

More positions owned by Point72 Asset Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Arista Networks Com Shs (ANET)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Amazon (AMZN)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Biogen Idec (BIIB)
Meta Platforms Cl A (META)
Teradyne (TER)
Advanced Micro Devices (AMD)
Asml Holding N V N Y Registry Shs (ASML)
Broadcom (AVGO)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Airbnb Com Cl A (ABNB)

View all positions for Point72 Asset Management

Top funds holding Aptevo Therapeutics

Point72 Asset Management
DRW Holdings
Virtu Financial
Colony
Advisor Group Holdings
UBS Group
Tower Research Capital
SBI Securities
BlackRock
Danske Bank A/s

View all funds holding Aptevo Therapeutics